Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
about
Outcomes of extremely low birth weight infants given early high-dose erythropoietin.Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?The developing oligodendrocyte: key cellular target in brain injury in the premature infantNeurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion.Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal ratsThe biological basis of injury and neuroprotection in the fetal and neonatal brain.Elevated endogenous erythropoietin concentrations are associated with increased risk of brain damage in extremely preterm neonatesPossibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.Congenital cardiac anomalies and white matter injuryCognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report.Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy.Preschool Assessment of Preterm Infants Treated With Darbepoetin and ErythropoietinAnti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurityA randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infantsTesting the sensitivity of Tract-Based Spatial Statistics to simulated treatment effects in preterm neonates.Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment conceptsRecombinant human erythropoietin improves neurological outcomes in very preterm infants.Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.Protective effect of maternal uteroplacental insufficiency on oxygen-induced retinopathy in offspring: removing bias of premature birthErythropoietin for infants with hypoxic-ischemic encephalopathy.Inflammatory injury to the neonatal brain - what can we do?Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.Mechanisms and management of retinopathy of prematurity.VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.Awaiting evidence of neuroprotective effects of recombinant erythropoietin in very preterm infants.Erythropoietin attenuates motor neuron programmed cell death in a burn animal model.Differential short-term regional effects of early high dose erythropoietin on white matter in preterm lambs after mechanical ventilation.Chorioamnionitis, neuroinflammation, and injury: timing is key in the preterm ovine fetus.
P2860
Q33642422-65509237-A41A-4D88-9E9B-9963955BA421Q34504572-51F6850B-B46A-46A4-BBED-8C376E975B63Q34995998-BECD1641-95B3-4B59-998B-43709F289DE9Q35046525-FD58F9BF-554E-4D7D-A9BF-C22BB4071509Q35181502-E32A89A9-701D-4B9C-A66E-5244C4A2238DQ35201430-72C5F3B5-A37B-4657-B6C6-3AEB44B9EDE2Q35202607-327C74AB-B9DF-434F-BF2F-BA05CC5A76EBQ35225120-AFB0BCC0-4D63-4D5D-A088-64FE3909846FQ35706661-B08AF2CA-E2B3-4041-A665-DD04FD7E50ACQ35935811-1E293EFF-3257-4F1F-BB21-EA5C65FCB5B0Q36070895-5CA3EC3C-DE88-4464-943F-5488D46F73A3Q36494891-82114AC8-5CF9-439A-8564-F018E419899CQ36630778-86893A77-DBCE-49FA-9A40-61F588AAD786Q36752978-D9E0C0E9-8F04-42AA-BE64-1D363EF7491CQ36952268-8E9CB0B0-CF7A-4A8F-BAA7-32A17C1BF2C3Q36981158-98173706-9551-42F5-B7F9-7B58999B8044Q37347049-0AD801F8-A5B1-42FE-AB02-28B6FC6B9556Q37375616-95653FF8-4ADD-4F21-9143-9B3AE8E4779BQ37416401-2810BC2B-31EF-4246-AAE6-6C7F3B52334AQ37640165-8CB94D77-0A03-4595-88C4-CDA3E23060E2Q37678885-6F7122ED-D88B-4BA5-A9CC-1AA474335B0DQ37705471-DAD6490C-652B-48E1-8BA1-1D50C8507CC2Q37938732-42BEFD8B-877C-4583-B851-1B534CC28D57Q38069895-8B6054B9-23DE-46B8-8840-0DBA13CC6920Q42044757-83272E69-1A0A-4F27-A669-8966F8686504Q44733105-76391B78-2D0B-4365-88A8-F4B70E409BD7Q48133730-8D9E749A-D374-4EC3-A4CC-9CE1D39339F0Q51598694-BFE4E0E5-B5F6-40E2-A111-47F7C7EF7C09Q52577385-F2823766-3398-462B-80C8-1729B17CD15D
P2860
Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
@en
Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
@nl
type
label
Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
@en
Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
@nl
prefLabel
Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
@en
Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
@nl
P2093
P356
P1433
P1476
Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
@en
P2093
Brenda Lala-Black
Delphine Eichorst
Mark S Brown
Robin Gonzalez
P304
P356
10.1542/PEDS.2008-2701
P407
P577
2009-09-28T00:00:00Z